Effect of N-benzoyl-D-phenylalanine, a new potential oral antidiabetic agent, in neonatal streptozotocin-induced diabetes in rats

Pharmacological Reports

Volumn 57, Issue 4, 2005, Pages 498-503

  Pari, Leelavinothan ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diabetes; Metformin; N benzoyl D phenylalanine; Streptozotocin

Indexed keywords

GLUCOSE; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; METFORMIN; N BENZOYLPHENYLALANINE DERIVATIVE; ORAL ANTIDIABETIC AGENT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOGLOBIN DETERMINATION; INFRARED SPECTROSCOPY; INSULIN BLOOD LEVEL; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; SCREENING TEST; STREPTOZOCIN DIABETES;

EID: 24744444140     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alberti KGMM, Zimmet PZ: For the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15, 539-553.
2. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 2001, 24, Suppl 1, 5-20.
3. Arthur Vogel I: Elementary Practical Organic Chemistry, Part 1, 2nd edn., CBS Publishers and Distributors, New Delhi, 1987, 270.
4. Bailey CJ, Turner RC: Metformin. N Engl J Med, 1996, 334, 574-579.
5. Bannon P: Effect of pH on the elimination of the labile fraction of glycosylated haemoglobin. Clin Chem, 1982, 28, 2183.
6. Bonner Weir S, Trent DF, Honey RN, Weir GC: Response of neonatal rat islets to streptozotocin. Limited β-cell regeneration and hyperglycemia. Diabetes, 1981, 30, 64-69.
7. Cavaghan MK, Khrmann DA, Polonsky KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest, 2000, 106, 329-333.
8. Christiansen MP, Linfoot PA, Neese RA, Hellerstein M: Metformin effects upon post-absorptive intra-hepatic carbohydrate fluxes. Diabetes, 1997, 46, Suppl 1, 244A.
9. Cusi K, Consoli A, DeFronzo RA: Metabolic effect of metformin on glucose and lactate metebolism in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1996, 81, 4059-4067.
10. Cusi K, DeFronzo RA: Metformin: a review of its metabolic effects. Diabetes Rev, 1998, 6, 98-131.
11. Drabkin DL, Austin JM: Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem, 1932, 98, 719-733.
12. Duncan BD: Multiple range test for correlated and heteroscedastic means. Biometrics, 1957, 13, 359-364.
13. Du Vigneaud V, Karr WG: Carbohydrates utilization: rate of disappearance of D-glucose from the blood. J Biol Chem, 1925, 66, 281-300.
14. Fujitani S, Ikenoue T, Akiyoshi M, Maki T, Yada T: Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas. Metabolism, 1996, 45, 184-189.
15. 2+ influx. Endocrinology, 1994, 134, 1395-1400.
16. 14C] glucose in pancreatic islets in an animal model of type-2 diabetes. Int J Mol Med, 2002, 9, 381-384.
17. Gokhale MS, Shah DH, Hakim Z, Santani DD, Goyal RK: Effect of chronic treatment with amlodipine in non-insulin-dependent diabetic rats. Pharm Res, 1998, 37, 455-459.
18. Grover JK, Vats V, Rathi SS: Antihyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol, 2000, 73, 461-470.
19. Hemmings SJ, Spafford D: Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: characteristics and assessment of the status of the hepatic adrenergic receptors. Int J Biochem Cell Biol, 2000, 32, 905-919.
20. Junod A, Lambert AE, Stauffacher W, Renold AE: Diabetogenic effect of streptozotocin: relationship of dose to metabolic response. J Clin Invest, 1969, 48, 2129-2139.
21. Kahn SE: The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol, 2001, 86, 4047-4058.
22. Klimes I, Sebokova E, Gasperikova D, Mitkova A, Kuklova S, Bohov J, Stanek J: Search for extra pancreatic effects of new oral hypoglycemic agent A-1466. 1. Oral glucose tolerance tests in normal and hereditary insulin resistant rats. Endocrine Regul, 1998, 32, 115-123.
23. Miura T, Usami M, Tsuura Y, Ishida H, Seino Y. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol Pharm Bull, 1995, 18, 1623-1625.
24. Morales MA, Jabbagy AJ, Tenenzi HP: Mutation affecting accumulation of glycogen. Neurospora News Lett, 1973, 20, 24-25.
25. Nayak SS, Pattabiraman TN: A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chem Acta, 1981, 109, 267-274.
26. 2+ oscillations in pancreatic beta-cells. Biochim Biophys Acta, 1992, 113, 295-305.
27. Peters AL, Davidson MB, Schriger DL, Hasseblad V A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta Analysis Research Group on the Diagnosis of Diabetes Using Glycosylated Hemoglobin Levels. JAMA, 1996, 276, 1246-1252.
28. Sasaki T, Matsy S, Sonae A: Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku, 1972, 1, 346-353.
29. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest, 2000, 106, 171-176.
30. Soon YY, Tan BKH: Evaluation of the hypoglycemic and antioxidant activities of Morida officinalis in streptozotocin-induced diabetes rats. Singapore Med J, 2000, 43, 77-85.
31. Stumvoll M, Nurjhan N, Periello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med, 1995, 333, 550-554.
32. Tanaka Y, Atsumi Y, Matsukoa K, Mokubo A, Asahina T, Hosokawa K, Shimada S et al.: Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects. Diabetes Res Clin Pract, 2001, 53, 41-45.'
33. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS). Lancet, 1998, 352, 837-853.
34. Weir GC, Clore ET, Zmachinski CJ: Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes, 1981, 30, 590-595.
35. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest, 1999, 104, 787-794.